KRAS and pancreatic adenocarcinoma: KRAS proto-oncogene, GTPase (KRAS), and tumor protein p53 (TP53) were confirmed to be important biomarkers for the prognosis of PAAD, and can also be used as a tool for treatment prediction [7].